EUROPEAN SOCIETY FOR HYBRID, MOLECULAR AND TRANSLATIONAL IMAGING

CHILI 2018

20 Lectures
297 Minutes
12 Speakers

ESR MEMBERS €19
NON-MEMBERS €29

No access granted. Register to watch.

Description

Learning Objectives

to learn the principles of hybrid medical imaging
to learn the key clinical questions at different points in the patient’s journey
to understand the indications, limitations and comparative merits of each part in hybrid medical imaging in a wide range of oncologic and non-oncologic conditions, including lymphoma, melanoma, prostate cancer, as well as neuro-endocrine tumors
to appreciate the complementary roles of structural and functional/molecular imaging in cancer management
to understand how information derived from imaging guides patient selection for treatment and supports individualised treatment planning
to learn about advanced applications of hybrid imaging, such as combined PET/MRI, new radiopharmaceuticals and artificial intelligence in hybrid imaging

Content

The four sessions at CHILI are ascending in level, tailored to your own degree of expertise and interests. All sessions include 3 lectures of approx. 20 minutes and end with a round table discussion.

Session 1 – The basics of hybrid imaging

The basics of hybrid imaging	Ivo Rausch
18F-FDG PET/CT in oncology with clinical case review	José L. Vercher-Conejero
PET/CT in imaging inflammation, infection and benign tumours	Jean-Noël Talbot
Round Table Discussion

Session 2 – Clinical application of hybrid imaging I

PET/CT in lymphoma	Francesca Giunta
PET/CT in melanoma	Helle Westergren Hendel
18F-FDG PET/CT in oncology: Pitfalls with clinical case review	Christina Pfannenberg
Round Table Discussion

Session 3 – Clinical application of hybrid imaging II

PET/CT in neuro-endocrine tumours	Jann Mortensen
The role of PSMA hybrid imaging in the clinical management of prostate cancer	Clemens Cyran
Theragnostics: hybrid imaging and radionuclide therapy	Harun Ilhan
Round Table Discussion

Session 4 – Advanced applications in hybrid imaging

Combined PET/MRI: Methods & application	Thomas Beyer
Far beyond FDG: Future targets for new radiopharmaceuticals in hybrid imaging?	Harun Ilhan
Artificial intelligence in hybrid imaging – the best of all worlds?	Irène Buvat
Round Table Discussion